Global FDA Grade Weight-Loss Devices Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Gastric Band
Electrical Stimulation Systems
Gastric Balloon Systems
Gastric Emptying Systems
Others
Segment by Application
Hospital
Clinic
Household
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
ReShape Medical
Helioscopie Medical Implants
Allurion
Spatz FGIA
Lexal
Obalon
Medsil
Endalis
Districlass Medical
Medicone
Silimed
Ethicon
Millennium Surgical
MID (Medical Innovation Developpement)
Apollo Endosurgery
Cousin Biotech

Table of Content
1 FDA Grade Weight-Loss Devices Market Overview
1.1 Product Overview and Scope of FDA Grade Weight-Loss Devices
1.2 FDA Grade Weight-Loss Devices Segment by Type
1.2.1 Global FDA Grade Weight-Loss Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Gastric Band
1.2.3 Electrical Stimulation Systems
1.2.4 Gastric Balloon Systems
1.2.5 Gastric Emptying Systems
1.2.6 Others
1.3 FDA Grade Weight-Loss Devices Segment by Application
1.3.1 FDA Grade Weight-Loss Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global FDA Grade Weight-Loss Devices Market Size Estimates and Forecasts
1.4.1 Global FDA Grade Weight-Loss Devices Revenue 2016-2027
1.4.2 Global FDA Grade Weight-Loss Devices Sales 2016-2027
1.4.3 FDA Grade Weight-Loss Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 FDA Grade Weight-Loss Devices Market Competition by Manufacturers
2.1 Global FDA Grade Weight-Loss Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global FDA Grade Weight-Loss Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global FDA Grade Weight-Loss Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers FDA Grade Weight-Loss Devices Manufacturing Sites, Area Served, Product Type
2.5 FDA Grade Weight-Loss Devices Market Competitive Situation and Trends
2.5.1 FDA Grade Weight-Loss Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest FDA Grade Weight-Loss Devices Players Market Share by Revenue
2.5.3 Global FDA Grade Weight-Loss Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 FDA Grade Weight-Loss Devices Retrospective Market Scenario by Region
3.1 Global FDA Grade Weight-Loss Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global FDA Grade Weight-Loss Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America FDA Grade Weight-Loss Devices Market Facts & Figures by Country
3.3.1 North America FDA Grade Weight-Loss Devices Sales by Country
3.3.2 North America FDA Grade Weight-Loss Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe FDA Grade Weight-Loss Devices Market Facts & Figures by Country
3.4.1 Europe FDA Grade Weight-Loss Devices Sales by Country
3.4.2 Europe FDA Grade Weight-Loss Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific FDA Grade Weight-Loss Devices Market Facts & Figures by Region
3.5.1 Asia Pacific FDA Grade Weight-Loss Devices Sales by Region
3.5.2 Asia Pacific FDA Grade Weight-Loss Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America FDA Grade Weight-Loss Devices Market Facts & Figures by Country
3.6.1 Latin America FDA Grade Weight-Loss Devices Sales by Country
3.6.2 Latin America FDA Grade Weight-Loss Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa FDA Grade Weight-Loss Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa FDA Grade Weight-Loss Devices Sales by Country
3.7.2 Middle East and Africa FDA Grade Weight-Loss Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global FDA Grade Weight-Loss Devices Historic Market Analysis by Type
4.1 Global FDA Grade Weight-Loss Devices Sales Market Share by Type (2016-2021)
4.2 Global FDA Grade Weight-Loss Devices Revenue Market Share by Type (2016-2021)
4.3 Global FDA Grade Weight-Loss Devices Price by Type (2016-2021)
5 Global FDA Grade Weight-Loss Devices Historic Market Analysis by Application
5.1 Global FDA Grade Weight-Loss Devices Sales Market Share by Application (2016-2021)
5.2 Global FDA Grade Weight-Loss Devices Revenue Market Share by Application (2016-2021)
5.3 Global FDA Grade Weight-Loss Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 ReShape Medical
6.1.1 ReShape Medical Corporation Information
6.1.2 ReShape Medical Description and Business Overview
6.1.3 ReShape Medical FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 ReShape Medical Product Portfolio
6.1.5 ReShape Medical Recent Developments/Updates
6.2 Helioscopie Medical Implants
6.2.1 Helioscopie Medical Implants Corporation Information
6.2.2 Helioscopie Medical Implants Description and Business Overview
6.2.3 Helioscopie Medical Implants FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Helioscopie Medical Implants Product Portfolio
6.2.5 Helioscopie Medical Implants Recent Developments/Updates
6.3 Allurion
6.3.1 Allurion Corporation Information
6.3.2 Allurion Description and Business Overview
6.3.3 Allurion FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Allurion Product Portfolio
6.3.5 Allurion Recent Developments/Updates
6.4 Spatz FGIA
6.4.1 Spatz FGIA Corporation Information
6.4.2 Spatz FGIA Description and Business Overview
6.4.3 Spatz FGIA FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Spatz FGIA Product Portfolio
6.4.5 Spatz FGIA Recent Developments/Updates
6.5 Lexal
6.5.1 Lexal Corporation Information
6.5.2 Lexal Description and Business Overview
6.5.3 Lexal FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lexal Product Portfolio
6.5.5 Lexal Recent Developments/Updates
6.6 Obalon
6.6.1 Obalon Corporation Information
6.6.2 Obalon Description and Business Overview
6.6.3 Obalon FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Obalon Product Portfolio
6.6.5 Obalon Recent Developments/Updates
6.7 Medsil
6.6.1 Medsil Corporation Information
6.6.2 Medsil Description and Business Overview
6.6.3 Medsil FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Medsil Product Portfolio
6.7.5 Medsil Recent Developments/Updates
6.8 Endalis
6.8.1 Endalis Corporation Information
6.8.2 Endalis Description and Business Overview
6.8.3 Endalis FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Endalis Product Portfolio
6.8.5 Endalis Recent Developments/Updates
6.9 Districlass Medical
6.9.1 Districlass Medical Corporation Information
6.9.2 Districlass Medical Description and Business Overview
6.9.3 Districlass Medical FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Districlass Medical Product Portfolio
6.9.5 Districlass Medical Recent Developments/Updates
6.10 Medicone
6.10.1 Medicone Corporation Information
6.10.2 Medicone Description and Business Overview
6.10.3 Medicone FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Medicone Product Portfolio
6.10.5 Medicone Recent Developments/Updates
6.11 Silimed
6.11.1 Silimed Corporation Information
6.11.2 Silimed FDA Grade Weight-Loss Devices Description and Business Overview
6.11.3 Silimed FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Silimed Product Portfolio
6.11.5 Silimed Recent Developments/Updates
6.12 Ethicon
6.12.1 Ethicon Corporation Information
6.12.2 Ethicon FDA Grade Weight-Loss Devices Description and Business Overview
6.12.3 Ethicon FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Ethicon Product Portfolio
6.12.5 Ethicon Recent Developments/Updates
6.13 Millennium Surgical
6.13.1 Millennium Surgical Corporation Information
6.13.2 Millennium Surgical FDA Grade Weight-Loss Devices Description and Business Overview
6.13.3 Millennium Surgical FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Millennium Surgical Product Portfolio
6.13.5 Millennium Surgical Recent Developments/Updates
6.14 MID (Medical Innovation Developpement)
6.14.1 MID (Medical Innovation Developpement) Corporation Information
6.14.2 MID (Medical Innovation Developpement) FDA Grade Weight-Loss Devices Description and Business Overview
6.14.3 MID (Medical Innovation Developpement) FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.14.4 MID (Medical Innovation Developpement) Product Portfolio
6.14.5 MID (Medical Innovation Developpement) Recent Developments/Updates
6.15 Apollo Endosurgery
6.15.1 Apollo Endosurgery Corporation Information
6.15.2 Apollo Endosurgery FDA Grade Weight-Loss Devices Description and Business Overview
6.15.3 Apollo Endosurgery FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Apollo Endosurgery Product Portfolio
6.15.5 Apollo Endosurgery Recent Developments/Updates
6.16 Cousin Biotech
6.16.1 Cousin Biotech Corporation Information
6.16.2 Cousin Biotech FDA Grade Weight-Loss Devices Description and Business Overview
6.16.3 Cousin Biotech FDA Grade Weight-Loss Devices Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Cousin Biotech Product Portfolio
6.16.5 Cousin Biotech Recent Developments/Updates
7 FDA Grade Weight-Loss Devices Manufacturing Cost Analysis
7.1 FDA Grade Weight-Loss Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of FDA Grade Weight-Loss Devices
7.4 FDA Grade Weight-Loss Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 FDA Grade Weight-Loss Devices Distributors List
8.3 FDA Grade Weight-Loss Devices Customers
9 FDA Grade Weight-Loss Devices Market Dynamics
9.1 FDA Grade Weight-Loss Devices Industry Trends
9.2 FDA Grade Weight-Loss Devices Growth Drivers
9.3 FDA Grade Weight-Loss Devices Market Challenges
9.4 FDA Grade Weight-Loss Devices Market Restraints
10 Global Market Forecast
10.1 FDA Grade Weight-Loss Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of FDA Grade Weight-Loss Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of FDA Grade Weight-Loss Devices by Type (2022-2027)
10.2 FDA Grade Weight-Loss Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of FDA Grade Weight-Loss Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of FDA Grade Weight-Loss Devices by Application (2022-2027)
10.3 FDA Grade Weight-Loss Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of FDA Grade Weight-Loss Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of FDA Grade Weight-Loss Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer